Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications
L Dayon, O Cominetti, M Affolter - Expert review of proteomics, 2022 - Taylor & Francis
Introduction Biological fluids are routine samples for diagnostic testing and monitoring.
Blood samples are typically measured because of their moderate invasive collection and …
Blood samples are typically measured because of their moderate invasive collection and …
Applications of tandem mass spectrometry (MS/MS) in protein analysis for biomedical research
AN Neagu, M Jayathirtha, E Baxter, M Donnelly… - Molecules, 2022 - mdpi.com
Mass Spectrometry (MS) allows the analysis of proteins and peptides through a variety of
methods, such as Electrospray Ionization-Mass Spectrometry (ESI-MS) or Matrix-Assisted …
methods, such as Electrospray Ionization-Mass Spectrometry (ESI-MS) or Matrix-Assisted …
Human CNS barrier-forming organoids with cerebrospinal fluid production
L Pellegrini, C Bonfio, J Chadwick, F Begum, M Skehel… - Science, 2020 - science.org
INTRODUCTION The choroid plexus is a secretory epithelial tissue of the central nervous
system (CNS) responsible for cerebrospinal fluid (CSF) production and functions as a barrier …
system (CNS) responsible for cerebrospinal fluid (CSF) production and functions as a barrier …
Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease
Parkinson's disease (PD) is a growing burden worldwide, and there is no reliable biomarker
used in clinical routines to date. Cerebrospinal fluid (CSF) is routinely collected in patients …
used in clinical routines to date. Cerebrospinal fluid (CSF) is routinely collected in patients …
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies
K Brockmann, C Quadalti, S Lerche, M Rossi… - Acta neuropathologica …, 2021 - Springer
The clinicopathological heterogeneity in Lewy-body diseases (LBD) highlights the need for
pathology-driven biomarkers in-vivo. Misfolded alpha-synuclein (α-Syn) is a lead candidate …
pathology-driven biomarkers in-vivo. Misfolded alpha-synuclein (α-Syn) is a lead candidate …
Putting humpty dumpty back together again: what does protein quantification mean in bottom-up proteomics?
Bottom-up proteomics provides peptide measurements and has been invaluable for moving
proteomics into large-scale analyses. Commonly, a single quantitative value is reported for …
proteomics into large-scale analyses. Commonly, a single quantitative value is reported for …
Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease
W Paslawski, S Khosousi, E Hertz, I Markaki… - Translational …, 2023 - Springer
Background There is a need for biomarkers to support an accurate diagnosis of Parkinson's
disease (PD). Cerebrospinal fluid (CSF) has been a successful biofluid for finding …
disease (PD). Cerebrospinal fluid (CSF) has been a successful biofluid for finding …
Global, in situ analysis of the structural proteome in individuals with Parkinson's disease to identify a new class of biomarker
MT Mackmull, L Nagel, F Sesterhenn… - Nature structural & …, 2022 - nature.com
Parkinson's disease (PD) is a prevalent neurodegenerative disease for which robust
biomarkers are needed. Because protein structure reflects function, we tested whether …
biomarkers are needed. Because protein structure reflects function, we tested whether …
A proteogenomic view of Parkinson's disease causality and heterogeneity
S Kaiser, L Zhang, B Mollenhauer, J Jacob… - npj Parkinson's …, 2023 - nature.com
The pathogenesis and clinical heterogeneity of Parkinson's disease (PD) have been
evaluated from molecular, pathophysiological, and clinical perspectives. High-throughput …
evaluated from molecular, pathophysiological, and clinical perspectives. High-throughput …
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
JP Quinn, SE Kandigian, BA Trombetta… - Brain …, 2021 - academic.oup.com
Neurosecretory protein VGF (non-acronymic) belongs to the granin family of neuropeptides.
VGF and VGF-derived peptides have been repeatedly identified in well-powered and well …
VGF and VGF-derived peptides have been repeatedly identified in well-powered and well …